Target: U.S. Preventive Services Task Force
Goal: Stop discouraging prostate cancer screening.
Recently, a government task force has released a recommendation that men should not get regular tests for prostate cancer. They claim that the test will harm more people than it will save. The task force found that 1 man in 1000 will have his life saved by the test, while 1 in 3000 will die from complications related to the screening. To save these 1 in 3000, the U.S. Preventive Services Task Force has suggested no one should be tested for this cancer.
This recommendation has been met with criticism from the American Urological Association, who have said they are ‘outraged’ by this statement. The recommendation to avoid routine screenings will lead to men who are showing symptoms of prostate cancer avoiding diagnostic tests. Additionally, insurance companies may not cover this test because of this recommendation. This will lead to men who need the test for diagnostic purposes being unable to afford it.
Even though the screening test for prostate cancer was not estimated to save many lives, it is undeniable that it is truly life-saving for some. By discouraging the test, this task force will prevent those lives from being saved. While routine screening may not be useful, this test must still be recommended as a diagnostic procedure, and those who need it should not be discouraged from undergoing it.
Dear U.S. Preventive Services Task Force,
Recently, you recommended that men should not get routine screenings for prostate cancer. This recommendation is discouraging men from getting this screening test for any reason, including diagnostic tests when symptoms of prostate cancer are present. Despite the risks of the screening test, it is important for saving some lives, and it should not be completely discouraged.
I ask you to stop discouraging men from getting this screening test. If a man is presenting symptoms of prostate cancer, this screening test is the best diagnostic course. However, your recommendation will prevent insurance companies from covering the test. If a man decides he needs the test, he may be unable to afford it because of this lack of coverage. Stop discouraging the use of this screening test when it is truly important in some cases.
[Your Name Here]